Stay updated on Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial

Sign up to get notified when there's something new on the Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Revision: v3.5.0 has been added and Revision: v3.4.3 has been removed.
    Difference
    0.0%
    Check dated 2026-03-21T20:53:10.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-07T13:00:19.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    Fallopian tube cancer is now listed as a condition on the page, and the page revision updated to v3.4.2 (replacing v3.4.1).
    Difference
    0.1%
    Check dated 2026-02-13T17:41:27.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Added 'Primary peritoneal carcinoma' to the conditions/terms and introduced a resources entry for the Genetic and Rare Diseases Information Center. Updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.2%
    Check dated 2026-02-06T11:27:56.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.0 to v3.4.1. This appears to be a behind-the-scenes update with no visible changes to the study details or page content.
    Difference
    0.0%
    Check dated 2026-02-05T11:34:17.000Z thumbnail image
  8. Check
    52 days ago
    Change Detected
    Summary
    UI changes include a Show glossary toggle and updates to metadata labels (Last Update Submitted that Met QC Criteria; Revision: v3.4.0) with capitalization adjustments and No FEAR Act Data text; older capitalization variants appear to have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-29T06:21:53.000Z thumbnail image

Stay in the know with updates to Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial page.